Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 475

1.

Surgery and radiofrequency ablation for treatment of liver metastases from midgut and foregut carcinoids and endocrine pancreatic tumors.

Eriksson J, Stålberg P, Nilsson A, Krause J, Lundberg C, Skogseid B, Granberg D, Eriksson B, Akerström G, Hellman P.

World J Surg. 2008 May;32(5):930-8. doi: 10.1007/s00268-008-9510-3.

PMID:
18324347
2.

Hepatic surgery for metastases from neuroendocrine tumors.

Sarmiento JM, Que FG.

Surg Oncol Clin N Am. 2003 Jan;12(1):231-42. Review.

PMID:
12735141
3.

Aggressive surgery for metastatic liver neuroendocrine tumors.

Norton JA, Warren RS, Kelly MG, Zuraek MB, Jensen RT.

Surgery. 2003 Dec;134(6):1057-63; discussion 1063-5.

PMID:
14668741
4.

Gastrointestinal carcinoid tumors: factors that predict outcome.

Van Gompel JJ, Sippel RS, Warner TF, Chen H.

World J Surg. 2004 Apr;28(4):387-92. Epub 2004 Mar 4.

PMID:
14994141
5.

Biomarkers predict outcomes following cytoreductive surgery for hepatic metastases from functional carcinoid tumors.

Jensen EH, Kvols L, McLoughlin JM, Lewis JM, Alvarado MD, Yeatman T, Malafa M, Shibata D.

Ann Surg Oncol. 2007 Feb;14(2):780-5. Epub 2006 Dec 5.

PMID:
17146740
6.
7.

Progression of metastases and symptom improvement from laparotomy in midgut carcinoid tumors.

Makridis C, Rastad J, Oberg K, Akerström G.

World J Surg. 1996 Sep;20(7):900-6; discussion 907.

PMID:
8678969
8.

Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.

Ueno S, Sakoda M, Kubo F, Hiwatashi K, Tateno T, Baba Y, Hasegawa S, Tsubouchi H; Kagoshima Liver Cancer Study Group.

J Hepatobiliary Pancreat Surg. 2009;16(3):359-66. doi: 10.1007/s00534-009-0069-7. Epub 2009 Mar 20.

PMID:
19300896
9.

Combined liver surgery and RFA for patients with gastroenteropancreatic endocrine tumors presenting with more than 15 metastases to the liver.

Elias D, Goéré D, Leroux G, Dromain C, Leboulleux S, de Baere T, Ducreux M, Baudin E.

Eur J Surg Oncol. 2009 Oct;35(10):1092-7. doi: 10.1016/j.ejso.2009.02.017. Epub 2009 May 21.

PMID:
19464140
10.

Radiofrequency ablation of neuroendocrine liver metastases: the Middlesex experience.

Gillams A, Cassoni A, Conway G, Lees W.

Abdom Imaging. 2005 Jul-Aug;30(4):435-41.

PMID:
15759207
11.

Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal liver metastases.

Hur H, Ko YT, Min BS, Kim KS, Choi JS, Sohn SK, Cho CH, Ko HK, Lee JT, Kim NK.

Am J Surg. 2009 Jun;197(6):728-36. doi: 10.1016/j.amjsurg.2008.04.013. Epub 2008 Sep 11.

PMID:
18789428
12.

Description of patients with midgut carcinoid tumours: clinical database from a Danish centre.

Nykjaer KM, Grønbaek H, Nielsen DT, Christiansen P, Astrup LB.

In Vivo. 2007 Jul-Aug;21(4):679-84.

13.

Surgical treatment as a principle in patients with advanced abdominal carcinoid tumors.

Søreide O, Berstad T, Bakka A, Schrumpf E, Hanssen LE, Engh V, Bergan A, Flatmark A.

Surgery. 1992 Jan;111(1):48-54.

PMID:
1728075
14.

Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.

Nikou GC, Lygidakis NJ, Toubanakis C, Pavlatos S, Tseleni-Balafouta S, Giannatou E, Mallas E, Safioleas M.

Hepatogastroenterology. 2005 May-Jun;52(63):731-41.

PMID:
15966194
15.
16.

Radiofrequency ablation for unresectable tumors of the liver.

Howard JH, Tzeng CW, Smith JK, Eckhoff DE, Bynon JS, Wang T, Arnoletti JP, Heslin MJ.

Am Surg. 2008 Jul;74(7):594-600; discussion 600-1.

PMID:
18646476
17.

Local treatment for recurrent colorectal hepatic metastases after partial hepatectomy.

van der Pool AE, Lalmahomed ZS, de Wilt JH, Eggermont AM, Ijzermans JM, Verhoef C.

J Gastrointest Surg. 2009 May;13(5):890-5. doi: 10.1007/s11605-008-0794-2. Epub 2009 Jan 9.

PMID:
19132450
18.

Cytoreductive surgery in patients with advanced-stage carcinoid tumors.

Gulec SA, Mountcastle TS, Frey D, Cundiff JD, Mathews E, Anthony L, O'Leary JP, Boudreaux JP.

Am Surg. 2002 Aug;68(8):667-71; discussion 671-2.

PMID:
12206599
19.

Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors.

Eriksson BK, Larsson EG, Skogseid BM, Löfberg AM, Lörelius LE, Oberg KE.

Cancer. 1998 Dec 1;83(11):2293-301.

PMID:
9840528
20.

Metastatic neuroendocrine hepatic tumors: resection improves survival.

Musunuru S, Chen H, Rajpal S, Stephani N, McDermott JC, Holen K, Rikkers LF, Weber SM.

Arch Surg. 2006 Oct;141(10):1000-4; discussion 1005.

PMID:
17043278

Supplemental Content

Support Center